Edition:
United States

Analyst Research

Report Title Price
Provider : ValuEngine, Inc.
$25.00
Provider : S&P Capital IQ Quantitative Report
$115.00
Provider : Reuters Investment Profile
$20.00
Provider : Thomson Reuters Stock Report
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

National Health Investors Inc raises low end of prior FY 2014 FFO guidance


Monday, 4 Aug 2014 01:20am EDT 

National Health Investors Inc:Says it has tightened FY 2014 Normalized FFO guidance to be in the range of $4.17 to $4.20 per diluted common share.Sees FY 2014 Normalized AFFO to be in the range of $3.72 to $3.75 per diluted common share. 

Company Quote

77.54
0.46 +0.60%
22 Jul 2016